The Medicines Company (MDCO) Soars As FDA Panel Approves Use Of Blood Clot Preventer

April 16, 2015 11:38 AM

1 0

An independent advisory panel to the FDA has ruled in favor of the approval of the company’s intravenous Cangrelor therapy to prevent blood clots

The Medicines Company (NASDAQ:MDCO) announced that its blood clot-preventing drug can now likely see approval for sale in the US for patients undergoing certain angioplasty procedures, as per the ruling of an independent advisory panel to the US Food and Drug Administration (FDA) on Wednesday. The F...

Read more

To category page